Research Options:

Week of Expected Pricing Withdrawn
Company Name Zars pharma, Inc
Proposed Ticker ZARS
CUSIP 98914Q101
Business Description A specialty pharmaceutical company focused on the development and commercialization of topically administered drugs.
Lead Underwriter Cowen and Company, CIBC World Markets
Co-Managers Leerink Swann & Company, Susquehanna Financial Group, LLLP
Initial Shares 5,000,000
Revised Initial Shares N/A
Initial Price $14.00-$16.00
Revised Price N/A
Final Price N/A
Final Ticker N/A

 

 

   
  © 2024 ICE Data Services. All rights reserved.